Creative Planning’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-2,500
Closed -$1K 4713
2016
Q4
$1K Buy
2,500
+1,500
+150% +$201K ﹤0.01% 4419
2016
Q3
$1K Sell
1,000
-1,000
-50% -$129K ﹤0.01% 4368
2016
Q2
$4K Hold
2,000
﹤0.01% 3741
2016
Q1
$6K Buy
2,000
+1,000
+100% +$134K ﹤0.01% 3485
2015
Q4
$2K Hold
1,000
﹤0.01% 4009
2015
Q3
$6K Buy
+1,000
New +$150K ﹤0.01% 3503

Other funds holding ELV

Creative Planning's ELV Position: Q1 2026 in Review

Creative Planning reduced its Elevance Health (ELV) stake by 12% in Q1 2026, selling an estimated $1.15M and leaving 26,847 shares worth $7.86M. The position accounts for 0.01% of the portfolio, ranked #858.

Creative Planning first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.9M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Creative Planning held 26,847 shares of Elevance Health worth $7.86M as of Q1 2026.
  • Creative Planning sold 3,514 Elevance Health shares in Q1 2026, an estimated $1.15M.
  • Elevance Health made up 0.01% of Creative Planning's portfolio in Q1 2026, its #858 holding.
  • Creative Planning first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • Creative Planning's Elevance Health position peaked at $16.9M in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.